104 related articles for article (PubMed ID: 8578839)
1. Immune response and protection against influenza A infection in mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.
Tamizifar H; Robinson A; Jennings R; Potter CW
Vaccine; 1995 Nov; 13(16):1539-46. PubMed ID: 8578839
[TBL] [Abstract][Full Text] [Related]
2. Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.
Tamizifar H; Jennings R; Ali SA; Potter CW
J Med Microbiol; 1997 Jan; 46(1):61-6. PubMed ID: 9003747
[TBL] [Abstract][Full Text] [Related]
3. Immune response of mice to immunization with subunit influenza A vaccine in DTP vaccine.
Potter CW; Tamizifar H; Jennings R
Vaccine; 1995 Feb; 13(3):253-60. PubMed ID: 7631510
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants.
Pichichero ME; Francis AB; Marsocci SM; Green JL; Disney FA
Am J Dis Child; 1993 Mar; 147(3):295-9. PubMed ID: 8438811
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR.
Miller E; Waight P; Laurichesse H; Andrews N; Thornton C; Sesardic D; Corbel M
Vaccine; 2001 Jul; 19(28-29):3904-11. PubMed ID: 11427264
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of an acellular pertussis vaccine booster in 15- to 20-month-old children previously immunized with acellular or whole-cell pertussis vaccine as infants.
Pichichero ME; Francis AB; Marsocci SM; Green JL; Disney FA; Meschievitz C
Pediatrics; 1993 Apr; 91(4):756-60. PubMed ID: 8464662
[TBL] [Abstract][Full Text] [Related]
7. Acellular pertussis vaccination of 2-month-old infants in the United States.
Pichichero ME; Francis AB; Blatter MM; Reisinger KS; Green JL; Marsocci SM; Disney FA
Pediatrics; 1992 May; 89(5 Pt 1):882-7. PubMed ID: 1579399
[TBL] [Abstract][Full Text] [Related]
8. The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice.
Cataldo DM; Van Nest G
Vaccine; 1997 Nov; 15(16):1710-5. PubMed ID: 9364672
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants.
Benne CA; Harmsen M; van der Graaff W; Verheul AF; Snippe H; Kraaijeveld CA
Vaccine; 1997 Jun; 15(9):1039-44. PubMed ID: 9261954
[TBL] [Abstract][Full Text] [Related]
10. IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines.
Ben-Ahmeida ET; Potter CW; Gregoriadis G; Adithan C; Jennings R
J Med Microbiol; 1994 Apr; 40(4):261-9. PubMed ID: 8151677
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
12. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
14. Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs.
Ghazi HO; Potter CW; Smith TL; Jennings R
J Med Microbiol; 1995 Jan; 42(1):53-61. PubMed ID: 7739026
[TBL] [Abstract][Full Text] [Related]
15. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.
Proudfoot O; Esparon S; Tang CK; Laurie K; Barr I; Pietersz G
BMC Infect Dis; 2015 Feb; 15():101. PubMed ID: 25887952
[TBL] [Abstract][Full Text] [Related]
16. Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effective adjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines.
Nagai T; Suzuki Y; Kiyohara H; Susa E; Kato T; Nagamine T; Hagiwara Y; Tamura S; Yabe T; Aizawa C; Yamada H
Vaccine; 2001 Sep; 19(32):4824-34. PubMed ID: 11535335
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes.
de Haan A; Geerligs HJ; Huchshorn JP; van Scharrenburg GJ; Palache AM; Wilschut J
Vaccine; 1995 Feb; 13(2):155-62. PubMed ID: 7625109
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant.
Ozaki T; Yauchi M; Xin KQ; Hirahara F; Okuda K
Viral Immunol; 2005; 18(2):373-80. PubMed ID: 16035949
[TBL] [Abstract][Full Text] [Related]
19. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
20. Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
Fan X; Su Q; Qiu F; Yi Y; Shen L; Jia Z; Liang P; Zou Y; Bi S
Vaccine; 2018 Jul; 36(29):4354-4361. PubMed ID: 29880240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
